This preliminary study investigated differences in immune response between non-smokers and people who use cigarettes or e-cigarettes by inoculating 47 participants with live attenuated influenza virus (LAIV). They found that at baseline, e-cigarette use disrupted normal immune response to viral...
Pulmonary Arterial Hypertension: Early Treatment with Selexipag Most Effective
New post-hoc analyses from the large-scale GRIPHON trial assessing selexipag in patients with pulmonary arterial hypertension (PAH) demonstrate that early, aggressive treatment after diagnosis is associated with the greatest benefits, irrespective of background therapy [1]. Around a third of PAH patients currently...